Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

2.

Kinetic therapy reduces complications and shortens hospital stay in patients with cardiogenic shock - a retrospective analysis.

Simonis G, Flemming K, Ziegs E, Haacke K, Rauwolf T, Strasser RH.

Eur J Cardiovasc Nurs. 2007 Mar;6(1):40-5. Epub 2006 May 15.

PMID:
16704935

Supplemental Content

Loading ...
Write to the Help Desk